Correction to: Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3b inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway (Molecular Pharmacology (2009) 76 (884–895) DOI: 10.1124/mol.109.058479);Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3β inhibition downstream of poly(ADP-ribose) polymerase-LKB1 pathway

Molecular Pharmacology

Volumn 76, Issue 4, 2009, Pages 884-895

  Sang, Mi Shin ^a,b   Il, Je Cho ^a   Sang, Geon Kim ^a  

^a Seoul National University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOBENZAMIDE; ADENYLATE KINASE; APIGENIN; ARACHIDONIC ACID; DAIDZEIN; GENISTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; IRON; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE LKBETA1; REACTIVE OXYGEN METABOLITE; RESVERATROL; RNA; SIRTUIN 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; OXIDATIVE STRESS; PRIORITY JOURNAL;

AMP-ACTIVATED PROTEIN KINASES; CELL LINE; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 70349324339     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.118.058479err     Document Type: Erratum

References (41)

1. Alessi DR, Sakamoto K, and Bayascas JR (2006) LKB1-dependent signaling pathways. Annu Rev Biochem 75:137-163.
2. Alvira D, Yeste-Velasco M, Folch J, Verdaguer E, Canudas AM, Pallàs M, and Camins A (2007) Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons. Neuroscience 147:746-756. (Pubitemid 46990651)
3. Balboa MA and Balsinde J (2006) Oxidative stress and arachidonic acid mobilization. Biochim Biophys Acta 1761:385-391. (Pubitemid 43776462)
4. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342. (Pubitemid 44764104)
5. Baur JA and Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493-506.
6. Browning JD and Horton JD (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147-152. (Pubitemid 39071617)
7. Cocco T, Di Paola M, Papa S, and LorussoM(1999) Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation. Free Radic Biol Med 27:51-59.
8. Dasgupta B and Milbrandt J (2007) Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci U S A 104:7217-7222. (Pubitemid 47186035)
9. Ferrali M, Signorini C, Sugherini L, Pompella A, Lodovici M, Caciotti B, Ciccoli L, and Comporti M (1997) Release of free, redox-active iron in the liver and DNA oxidative damage following phenylhydrazine intoxication. Biochem Pharmacol 53:1743-1751. (Pubitemid 27356105)
10. Fleming RE and Bacon BR (2005) Orchestration of iron homeostasis. N Engl J Med 352:1741-1744.
11. Galaris D and Pantopoulos K (2008) Oxidative stress and iron homeostasis: mechanistic and health aspects. Crit Rev Clin Lab Sci 45:1-23. (Pubitemid 351299652)
12. Hayashi T, Hirshman MF, Fujii N, Habinowski SA, Witters LA, and Goodyear LJ (2000) Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 49:527-531. (Pubitemid 30183739)
13. Hou X, Xu S, Maitland-Toolan KA, Sato K, Jiang B, Ido Y, Lan F, Walsh K, Wierzbicki M, Verbeuren TJ, et al. (2008) SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 283: 20015-20026.
14. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191-196. (Pubitemid 37150899)
15. Huang Q, Wu YT, Tan HL, Ong CN, and Shen HM (2009) A novel function of poly(ADP-ribose) polymerase-1 in modulation of autophagy and necrosis under oxidative stress. Cell Death Differ 16:264-277.
16. Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, Ha J, and Park OJ (2005) Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 338:694-699. (Pubitemid 41597699)
17. Ido Y, Carling D, and Ruderman N (2002) Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes 51:159-167. (Pubitemid 34517993)
18. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, et al. (2004) Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113:1535-1549. (Pubitemid 39071677)
19. Kajta M, Domin H, Grynkiewicz G, and Lason W (2007) Genistein inhibits glutamate-induced apoptotic processes in primary neuronal cell cultures: an involvement of aryl hydrocarbon receptor and estrogen receptor/glycogen synthase kinase-3beta intracellular signaling pathway. Neuroscience 145:592-604. (Pubitemid 46341646)
20. Kim EK, Kwon KB, Song MY, Seo SW, Park SJ, Ka SO, Na L, Kim KA, Ryu DG, So HS, et al. (2007) Genistein protects pancreatic beta cells against cytokine-mediated toxicity. Mol Cell Endocrinol 278:18-28. (Pubitemid 350183939)
21. Kim YW, Lee SM, Shin SM, Hwang SJ, Brooks JS, Kang HE, Lee MG, Kim SC, and Kim SG (2009) Efficacy of sauchinone as a novel AMPK-activating lignan for preventing iron-induced oxidative stress and liver injury. Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2009.07.018.
22. Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, and Rahman I (2008) Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 294:L478-L488.
23. Kukidome D, Nishikawa T, Sonoda K, Imoto K, Fujisawa K, Yano M, Motoshima H, Taguchi T, Matsumura T, and Araki E (2006) Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 55:120-127. (Pubitemid 43343306)
24. Kwon YN, Shin SM, Cho IJ, and Kim SG (2009) Oxidized metabolites of oltipraz exert cytoprotective effects against arachidonic acid through AMP-activated protein kinase-dependent cellular antioxidant effect and mitochondrial protection. Drug Metab Dispos 37:1187-1197.
25. Lage R, Diéguez C, Vidal-Puig A, and López M (2008) AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol Med 14:539-549.
26. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109-1122. (Pubitemid 44894520)
27. Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, and Shi X (2003) Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun 309:1017-1026. (Pubitemid 37122632)
28. Mahn K, Borrás C, Knock GA, Taylor P, Khan IY, Sugden D, Poston L, Ward JP, Sharpe RM, Viña J, et al. (2005) Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J 19:1755-1757. (Pubitemid 41429553)
29. Rahman I, Biswas SK, and Kirkham PA (2006) Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 72:1439-1452. (Pubitemid 44666744)
30. Rubiolo JA, Mithieux G, and Vega FV (2008) Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol 591: 66-72.
31. Sale S, Verschoyle RD, Boocock D, Jones DJ, Wilsher N, Ruparelia KC, Potter GA, Farmer PB, Steward WP, and Gescher AJ (2004) Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′- tetramethoxystilbene. Br J Cancer 90:736-744. (Pubitemid 38297218)
32. Scorrano L, Penzo D, Petronilli V, Pagano F, and Bernardi P (2001) Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha apoptotic signaling. J Biol Chem 276:12035-12040. (Pubitemid 37385366)
33. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, and Cantley LC (2004) The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 101:3329-3335. (Pubitemid 38338195)
34. Shin SM and Kim SG (2009) Inhibition of arachidonic acid and iron-induced mitochondrial dysfunction and apoptosis by oltipraz and novel 1,2-dithiole-3-thione congeners. Mol Pharmacol 75:242-253.
35. Tadolini B and Hakim G (1996) The mechanism of iron (III) stimulation of lipid peroxidation. Free Radic Res 25:221-227. (Pubitemid 26356525)
36. Terai K, Hiramoto Y, Masaki M, Sugiyama S, Kuroda T, Hori M, Kawase I, and Hirota H (2005) AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol Cell Biol 25:9554-9575. (Pubitemid 41507855)
37. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, and Weinberg RA (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107:149-159. (Pubitemid 33035942)
38. Vázquez-Chantada M, Ariz U, Varela-Rey M, Embade N, Martínez-Lopez N, Fernández-Ramos D, Gómez-Santos L, Lamas S, Lu SC, Martínez-Chantar ML, et al. (2009) Evidence for LKB1/AMP-activated protein kinase/ endothelial nitric oxide synthase cascade regulated by hepatocyte growth factor, S-adenosylmethionine, and nitric oxide in hepatocyte proliferation. Hepatology 49:608-617.
39. Wang HM, Mehta S, Bansode R, Huang W, and Mehta KD (2008) AICAR positively regulate glycogen synthase activity and LDL receptor expression through Raf-1/MEK/p42/44MAPK/p90RSK/GSK-3 signaling cascade. Biochem Pharmacol 75: 457-467. (Pubitemid 350298463)
40. Xi J, Wang H, Mueller RA, Norfleet EA, and Xu Z (2009) Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore. Eur J Pharmacol 604:111-116.
41. Zang M, Xu S, Maitland-Toolan KA, Zuccollo A, Hou X, Jiang B, Wierzbicki M, Verbeuren TJ, and Cohen RA (2006) Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55:2180-2191. (Pubitemid 44743614)